loading...

Ascites Impact Measure (AIM)

Sanofi Aventis

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed started in 2004; Published in 2012

AIM is adapted for daily completion using a 24-hour recall period however the use of the AIM at a weekly or monthly frequency is authorized (Information provided by the author)

Authors

Sanofi Aventis

Copyright
AIM © Sanofi-Aventis. All rights reserved.
Objective
To record patients’ daily experiences of symptoms that trigger a request for a paracentesis in patients with ascites
Therapeutic area
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication

Ascites

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Crawford B, Piault E, Gotlieb W, Joulain F. Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis. Patient Relat Outcome Meas. 2012 Jul;3:21-30 (Full Text)


Contact and conditions of use

Authors

Sanofi Aventis

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 1 000 €
Cost per language 1 000 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 700 €
Cost per language 300 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

AIM

Arabic for Israel*
Bengali for India*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for the UK*
Finnish for Finland*
French for Belgium*
French for France*
German for Germany*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Kannada for India*
Malayalam for India*
Marathi for India*
Norwegian for Norway*
Portuguese for Portugal*
Russian for Israel*
Russian for Russia*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Urdu for India*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us